Sriram Sathyanarayanan - 09 Jun 2021 Form 3 Insider Report for Codiak BioSciences, Inc.

Role
Chief Scientific Officer
Signature
/s/ Yalonda Howze, by Power of Attorney for Sriram Sathyanarayanan
Issuer symbol
N/A
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
3
Filing time
22 Jun 2021, 18:57:58 UTC
Next filing
28 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 51,266 $3.29 Direct F1
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 9,594 $10.17 Direct F2
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 8,314 $10.25 Direct F3
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 15,989 $10.25 Direct F4
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 19,188 $10.25 Direct F5
holding CDAKQ Stock Option (Right to Buy) 09 Jun 2021 Common Stock 16,000 $26.60 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested 25% on July 25, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.
F2 This option vested 25% on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter.
F3 This option vested 25% on July 31, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.
F4 This option vested 25% on January 15, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.
F5 This option vested 25% on January 9, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.
F6 This option shall vest 25% on January 22, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney